
Sign up to save your podcasts
Or
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
5
77 ratings
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
1,082 Listeners
854 Listeners
3,504 Listeners
9,306 Listeners
7,871 Listeners
619 Listeners
513 Listeners
28,406 Listeners
192 Listeners
1,600 Listeners
26 Listeners
1,143 Listeners
2,687 Listeners
1,149 Listeners